BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Pappas Capital, LLC
2520 Meridian Parkway
Suite 400
Durham, NC 27713
Mailing Address
P. O. Box 110287
Research Triangle Park, NC 27709
Tel: 919-998-3300
Fax: 919-998-3301
Email any member of our team by using an email address that begins with the first letter of the person’s first name, followed by the person’s last name, followed by “@pappas-capital.com” (e.g. John Smith’s email address would be jsmith@pappas-capital.com).
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.